Latest News and Press Releases

Half-Year Report Oxford Technology 2 VCT plc (the "Company") Unaudited Half Year Report to 31 August 2021 The Directors are pleased to attach the Company's unaudited Half Year...

The Board of OT2 VCT notes that Arecor Therapeutics plc (Arecor), which at 31 May 2021 was 42 % of the OT2 NAV of 27.17p/share was based on an Arecor share price of £2.26 which has now risen to £4.30...

Oxford Technology 2 VCT Plc 26 August 2021 Further to the announcement made by Oxford Technology 2  VCT Plc (the "Company") on 25 August 2021, the Board is pleased to announce that the Company has...

Proposals regarding the Sub-division and Reclassification of Share Capital Oxford Technology 2 VCT Plc 25 August 2021 This announcement is made by Oxford Technology 2 VCT Plc (the "Company")...

The Board of Oxford Technology 2 VCT PLC gives notice that all resolutions proposed at the AGM on Wednesday 25th August 2021 were passed on a poll. Details of proxy votes are included in the...

Previous Chairman’s statements in Annual and Interim reports have regularly referred to a desire by the Board to seek to increase the asset base of the Company. The most recent report issued at the...

Copies of the Annual Report and Accounts of the Company in respect of the financial period ended 28 February 2021 and the Notice of Annual General Meeting to be held on 25 August 2021, and Shareholder...

The Board is pleased to announce the Net Asset Value per share was 27.17p at 31 May 2021. Fuller details are included in the Annual Report for the year ended 28 February which was released...

Oxford Technology 2 VCT plc (the "Company") Annual Report & Financial Statements for the year ended 28 February 2021 The Directors are pleased to attach the Company's annual report...

The Board notes that on 3 June 2021 Arecor Therapeutics plc ("Arecor"), one of Oxford Technology 2 VCT Plc’s (“OT2”) investee companies, floated on AIM raising £20m via a placing at 226p per Arecor...